Nearsightedness Clinical Trial
Official title:
Vault Evaluation After Implantation of an Implantable Collamer Lens
The purpose of this study is to evaluate the lens vault after implantation of an implantable collamer lens (ICL). The ICL is designed to be implanted in front of the eye, without removing the natural lens. Because of this, it is also known as a phakic IOL. The ICL has already been approved by the U.S. Food and Drug Administration (FDA) to treat mid to high degrees of refractive errors such nearsightedness (also called myopia) with or without astigmatism. Once the artificial lens is implanted, a space between the ICL and the crystalline lens is created, which is called vault.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01013493 -
Association Between Breastfeeding and Likelihood of Myopia in 6-7 Years Old Children
|
N/A | |
| Active, not recruiting |
NCT02565537 -
High Resolution Wavefront-guided vs. Wavefront Optimized LASIK
|
N/A | |
| Recruiting |
NCT02576483 -
An Evaluation of LASIK, SMILE and PRK Surgery in Physicians
|
||
| Recruiting |
NCT00778570 -
Advanced Surface Ablation (ASA) vs Laser-Assisted In Situ Keratomileusis (LASIK)
|
N/A | |
| Completed |
NCT03479827 -
Measuring the Peripheral Optical Quality of The Eye
|
||
| Active, not recruiting |
NCT03918915 -
The Safety and Efficacy of SYD-101 in Children With Myopia
|
Phase 3 |